Colgate-Palmolive Co.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.70B | $15.50B | $15.20B | $16.00B | $17.30B | $17.40B | $17.10B | $17.30B |
| Oral, Personal and Home Care | $12.70B | $12.60B | $12.40B | $13.20B | $14.40B | $14.50B | $14.40B | $14.70B |
| Hill's Pet Nutrition | $3.00B | $2.90B | $2.80B | $2.80B | $2.90B | $2.90B | $2.70B | $2.60B |
| Cost of Revenue | $6.31B | $6.17B | $6.07B | $6.64B | $7.17B | $7.22B | $7.15B | $7.14B |
| Gross Profit | $9.23B | $9.28B | $9.12B | $9.40B | $10.11B | $10.20B | $9.93B | $9.59B |
| Gross Margin | 58.8% | 59.9% | 60.0% | 58.7% | 58.4% | 58.6% | 58.1% | 55.4% |
| Operating Expenses | ||||||||
| Research & Development | $277.0M | $285.0M | $289.0M | $274.0M | $277.0M | $267.0M | $259.0M | $262.0M |
| SG&A Expense | $5.39B | $5.40B | $5.14B | $5.46B | $5.98B | $6.22B | $5.93B | $5.76B |
| Operating Income | $3.69B | $3.71B | $3.96B | $2.79B | $3.56B | $3.56B | $3.89B | $3.84B |
| Operating Margin | 23.5% | 23.9% | 26.0% | 17.4% | 20.6% | 20.4% | 22.7% | 22.2% |
| Interest Expense | $195.0M | $156.0M | $155.0M | $139.0M | $134.0M | $119.0M | $81.0M | $59.0M |
| Pretax Income | $3.46B | $3.49B | $3.74B | $2.76B | $3.53B | $3.57B | $3.87B | $3.79B |
| Income Tax Expense | $906.0M | $1.31B | $1.15B | $1.22B | $1.19B | $1.16B | $1.24B | $1.24B |
| Net Income | $2.40B | $2.02B | $2.44B | $1.38B | $2.18B | $2.24B | $2.47B | $2.43B |
| Net Margin | 15.3% | 13.1% | 16.1% | 8.7% | 12.6% | 12.9% | 14.5% | 14.1% |
| EPS (Basic) | $2.76 | $2.30 | $2.74 | $1.53 | $2.38 | $2.41 | $2.60 | $2.49 |
| EPS (Diluted) | $2.75 | $2.28 | $2.72 | $1.52 | $2.36 | $2.38 | $2.57 | $2.47 |
| Shares Outstanding (Basic) | 870.6M | 881.8M | 891.8M | 902.2M | 915.1M | 930.8M | 952.1M | 976.7M |
| Shares Outstanding (Diluted) | 873.0M | 887.8M | 898.4M | 909.7M | 924.3M | 939.9M | 960.2M | 984.1M |
| Dividends Per Share | $1.66 | $1.59 | — | — | — | — | — | — |